BCL6 promotes the progression of high-grade serous ovarian cancer cells by inhibiting PLAAT4
BackgroundB-cell lymphoma 6 (BCL6) is increasingly recognized as a driver of cancer progression; however, the precise molecular mechanisms by which BCL6 facilitates high-grade serous ovarian cancer (HGSOC) progression remain incompletely understood.MethodsIn this study, immunohistochemical (IHC) sta...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1634995/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|